Sept 23 (Reuters) - Biotech company Arcturus Therapeutics (ARCT.O), opens new tab sued AbbVie (ABBV.N), opens new tab in California federal court on Tuesday for allegedly stealing trade secrets ...
A new COVID variant Arcturus has caused a huge uptick in infections in India. (Reuters) Five people in England have died from the new COVID variant dubbed Arcturus, the UK Health Security Agency ...
Arcturus Therapeutics (ARCT) shares soared 8.7% in the last trading session to close at $19.62. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...
Los Angeles County Department of Public Health confirmed three cases of the Arcturus strain with "observational data" suggesting that those infected may be likely to experience pink eye Los Angeles ...
Arcturus Therapeutics Holdings Inc. ARCT is engaged in developing messenger RNA (mRNA) medicines and vaccines based on its innovative and enabling technologies. San Diego, CA-based Arcturus has ...
Arcturus' mRNA vaccine will be trying to break into a crowded market if it gets approved. Moderna was in the right place at the right time, and Arcturus isn't. Yet, Arcturus doesn't need to sell many ...
Arcturus Therapeutics believes it’s “highly unlikely” it will lose the promised government funding for its bird flu mRNA vaccine trial, despite reports swirling that Moderna’s own financial support ...
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of ...
A new strain of SARS-CoV-2 has experts concerned The XBB.1.16 strain dubbed “Arcturus” was discovered in India and has spread to 29 other countries. This strain appears to lead to higher fevers than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback